- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/02 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
Patent holdings for IPC class C07D 237/02
Total number of patents in this class: 52
10-year publication summary
|
1
|
3
|
0
|
4
|
5
|
2
|
4
|
2
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Otsuka Pharmaceutical Co., Ltd. | 1498 |
5 |
| Boehringer Ingelheim International GmbH | 4636 |
2 |
| University of Florida Research Foundation, Inc. | 4089 |
2 |
| Northwestern University | 3457 |
2 |
| Afferent Pharmaceuticals, Inc. | 25 |
2 |
| Beijing Tide Pharmaceutical Co. Ltd. | 96 |
2 |
| Dana-Farber Cancer Institute, Inc. | 2626 |
2 |
| Neuropro Therapeutics, Inc. | 22 |
2 |
| University Health Network | 1055 |
2 |
| Hoffmann-La Roche Inc. | 3546 |
1 |
| Genentech, Inc. | 4016 |
1 |
| Merck Sharp & Dohme Corp. | 2189 |
1 |
| AstraZeneca AB | 2857 |
1 |
| Janssen Pharmaceutica N.V. | 3358 |
1 |
| Pfizer Inc. | 3401 |
1 |
| Merck Patent GmbH | 5752 |
1 |
| Allergan, Inc. | 2313 |
1 |
| Centre National de La Recherche Scientifique | 10706 |
1 |
| Bayer Cropscience AG | 1983 |
1 |
| Sumitomo Chemical Company, Limited | 9109 |
1 |
| Other owners | 20 |